Centro Medico Zambrano Hellion

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Aortic aneurysm1 trial
• High blood pressure1 trial
• Triple-negative breast cancer1 trial
• Type 2 diabetes1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Not yet recruiting2 trials
• Recruiting2 trials
• Completed1 trial

Lead sponsor

• Boehringer Ingelheim3 trials
• Hoffmann-La Roche1 trial
• Tecnologico de Monterrey1 trial

Running trials

• Not yet recruiting

  Aortic Size and Height Indices in Abdominal Aortic Aneurysms

  NCT07893704· Tecnologico de Monterrey· Source

  Contact: Mario A Fabiani, MD

• Recruiting

  DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

  NCT07472517· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

  NCT07195695· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer2 recruiting
• Aortic aneurysm1 recruiting
• High blood pressure1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer

  NCT05852691· Phase 2· Hoffmann-La Roche· Source